Studies Linking GLP-1 Medications to NAION Several peer-reviewed studies have confirmed an increased risk of NAION in patients taking GLP-1 drugs: Harvard Medical School & Mass General Brigham Study (JAMA Ophthalmology, 2024) 9% of diabetic patients taking semaglutide developed NAION, compared to 1.8% on other diabetes drugs (a 4-fold increased risk)
Listen to Medical Advice After you state your case to the doctor, be open to what they have to say
GCG signaling Unlike GLP-1 and GIP receptors, GCG show robust hepatic expression, enabling direct hepatic metabolic effects
Membership costs $149 per month after the first month, not including the price of medication
They were features designed to increase engagement in the Noom appnew health insights that catalyze motivation, new microhabits that make it easier to support your health on any given day, and rewards to help you sustain motivation to keep at it every day
Neff LM, Kushner RF